BOGER JOSHUA S 4

What Happened

• Joshua S. Boger, reported as a 10% owner of CervoMed, Inc. (CRVO), was granted an option to purchase 8,150 shares of common stock. The Form 4 (period of report 2026-06-08; filed 2026-06-10) reports the award as a derivative acquisition with an acquisition price listed as $0.00 (grant of an option rather than an immediate stock purchase). This is an equity award issued pursuant to the company's 2025 Equity Incentive Plan under the issuer's non-employee director compensation policy.

Key Details

• Transaction date: June 8, 2026; Filing date: June 10, 2026 (timely filing).
• Award: Option to purchase 8,150 shares; Form 4 shows acquisition at $0.00 (reflecting grant of an option).
• Vesting: Shares underlying the award vest monthly over one year in substantially equal 1/12 increments on the last day of each month beginning June 30, 2026, subject to continued service.
• Exercise/strike price and post-transaction beneficial ownership were not specified in the excerpt provided.
• Footnote: Award made in connection with Boger’s election to the company’s board at the 2026 Annual Meeting; granted per non-employee director compensation policy.

Context

• This is a standard director equity grant (derivative award) rather than an open-market purchase or sale. Such awards are routine compensation for board service and do not necessarily signal a personal market view; they give the director the right to buy shares in the future subject to vesting and exercise terms.